Mr. William J. Maggio is a healthcare, medical diagnostics and business development executive from Buffalo, New York. Building on BD experience with Boehringer Mannheim and Roche, he was instrumental in the expansion of Immco Diagnostics, Inc. and its acquisition by Trinity Biotech PLC (NASDAQ: TRIB). Mr. Maggio continues to serve as CEO and President of Immco and has taken a leadership role in a number of other health care and biotech ventures. He is a Managing Partner at Lorraine Capital LLC, Buffalo, New York; Entrepreneur in Residency at Convergent Health Care Partners LLC, Chicago, Illinois; CEO of The Jacobs Institute and Gates Vascular Institute, Buffalo, New York; and Chairman of Fitzgerald Antibodies Inc, Boston, Massachusetts.

Mr. Maggio remains very active in the Buffalo Community as Chair, Director, and Advisor on a number of local, National and International boards including the University at Buffalo Foundation Board of Directors, Kaleida Health Board of Directors (Vice Chair), Buffalo Philharmonic Orchestra, (Trustee) 43 North (Chair), the West Side Rowing Club (Past Chair), and the Burchfield Penny Art Center.